Early Coronary Artery Calcification Progression over Two Years in Breast Cancer Patients Treated with Radiation Therapy: Association with Cardiac Exposure (BACCARAT Study).
breast cancer
cardiotoxicity
coronary artery calcification
dosimetry
radiation therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Nov 2022
22 Nov 2022
Historique:
received:
13
10
2022
revised:
08
11
2022
accepted:
20
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
12
12
2022
Statut:
epublish
Résumé
Background: Radiotherapy (RT) for breast cancer (BC) can induce coronary artery disease many years after RT. At an earlier stage, during the first two years after RT, we aimed to evaluate the occurrence of increased coronary artery calcium (CAC) and its association with cardiac exposure. Methods: This prospective study included 101 BC patients treated with RT without chemotherapy. Based on CAC CT scans performed before and two years after RT, the event ‘CAC progression’ was defined by an increase in overall CAC score (CAC RT+ two years—CAC before RT > 0). Dosimetry was evaluated for whole heart, left ventricle (LV), and coronary arteries. Multivariable logistic regression models were used to assess association with doses. Results: Two years after RT, 28 patients presented the event ‘CAC progression’, explained in 93% of cases by a higher CAC score in the left anterior descending coronary (LAD). A dose−response relationship was observed with LV exposure (for Dmean LV: OR = 1.15, p = 0.04). LAD exposure marginally explained increased CAC in the LAD (for D2 LV: OR =1.03, p = 0.07). Conclusion: The risk of early CAC progression may be associated with LV exposure. This progression might primarily be a consequence of CAC increase in the LAD and its exposure.
Identifiants
pubmed: 36497205
pii: cancers14235724
doi: 10.3390/cancers14235724
pmc: PMC9735519
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fédération française de cardiologie
ID : AEPET2016-JF
Organisme : Électricité de France (France)
ID : CE2016-SJ
Organisme : H2020 Euratom research and training program 2014-2018
ID : 755523
Références
Strahlenther Onkol. 2016 Oct;192(10):696-704
pubmed: 27534410
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
Radiat Oncol. 2019 Feb 7;14(1):29
pubmed: 30732640
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S77-85
pubmed: 20171522
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Oncol. 2022 Jun 28;12:883679
pubmed: 35837099
Radiother Oncol. 2018 Jan;126(1):170-176
pubmed: 29089148
Radiat Oncol. 2021 Nov 2;16(1):210
pubmed: 34727957
J Am Coll Cardiol. 2005 Sep 6;46(5):807-14
pubmed: 16139129
JAMA Oncol. 2021 Jul 01;7(7):1024-1032
pubmed: 33956083
Radiat Oncol. 2016 Apr 07;11:54
pubmed: 27056179
Mayo Clin Proc. 1999 Apr;74(4):347-55
pubmed: 10221462
J Am Coll Cardiol. 2010 Nov 9;56(20):1613-22
pubmed: 21050970
Breast. 2022 Oct;65:77-83
pubmed: 35870419
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
JACC CardioOncol. 2021 Sep 21;3(3):343-359
pubmed: 34604796
Radiother Oncol. 2015 Mar;114(3):328-34
pubmed: 25600105
JAMA. 2004 Jan 14;291(2):210-5
pubmed: 14722147
JMIR Res Protoc. 2018 Oct 01;7(10):e178
pubmed: 30274965
Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1272-7
pubmed: 15059806
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
Lancet. 2005 Dec 17;366(9503):2087-106
pubmed: 16360786
J Clin Oncol. 2012 Feb 1;30(4):380-6
pubmed: 22203772
Eur Heart J. 2004 Jan;25(1):48-55
pubmed: 14683742
Int J Cardiol. 2007 Apr 25;117(2):227-31
pubmed: 16875746
J Clin Oncol. 2017 Apr 10;35(11):1171-1178
pubmed: 28095159
Radiother Oncol. 2011 Aug;100(2):167-75
pubmed: 21752480
Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):409-415
pubmed: 35787926
Am J Cardiol. 2000 Jul 1;86(1):8-11
pubmed: 10867084
Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):421-6
pubmed: 11231923
Int J Cardiovasc Imaging. 2017 Sep;33(9):1425-1431
pubmed: 28342038